Detalhe da pesquisa
1.
Organokines and liver enzymes in adolescent girls with polycystic ovary syndrome during randomized treatments.
Front Endocrinol (Lausanne)
; 15: 1325230, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38818508
2.
SPIOMET4HEALTH-efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial.
Trials
; 24(1): 589, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715279
3.
Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.
BMJ Open Diabetes Res Care
; 8(1)2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107266
4.
Toward a Treatment Normalizing Ovulation Rate in Adolescent Girls With Polycystic Ovary Syndrome.
J Endocr Soc
; 4(5): bvaa032, 2020 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32342022
5.
Towards a circulating marker of hepato-visceral fat excess: S100A4 in adolescent girls with polycystic ovary syndrome - Evidence from randomized clinical trials.
Pediatr Obes
; 14(5): e12500, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30653851